Effect of prior bevacizumab treatment in BRAF V600Emutant metastatic colorectal cancer: Overall survival with encorafenib + cetuximab +/- binimetinib in BEACON CRC Meeting Abstract


Authors: Aderka, D.; Kopetz, S.; Grothey, A.; Van Cutsem, E.; Yaeger, R.; Wasan, H.; Yoshino, T.; Desai, J.; Ciardiello, F.; Golden, A.; Edwards, M.; Tabernero, J.
Abstract Title: Effect of prior bevacizumab treatment in BRAF V600Emutant metastatic colorectal cancer: Overall survival with encorafenib + cetuximab +/- binimetinib in BEACON CRC
Meeting Title: ESMO 23rd World Congress on Gastrointestinal Cancer
Journal Title: Annals of Oncology
Volume: 32
Issue: Suppl. 3
Meeting Dates: 2021 Jun 30-Jul 3
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2021-07-01
Start Page: S214
Language: English
ACCESSION: WOS:000670004200327
DOI: 10.1016/j.annonc.2021.05.052
PROVIDER: wos
Notes: Meeting Abstract: SO-28 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Rona Denit Yaeger
    315 Yaeger